Search

everythinglearnresearchcommunity

for

Search:↓

Vav2 changes how hair follicle stem cells' genes work as they age, which might improve regeneration but also raise cancer risk.

Aminoguanidine increases a specific growth signal in stored hair grafts, which may help them survive better after being transplanted.

AGA patients have lower serum vaspin levels, which might help detect the condition early.

C3G and Vitisin A may help prevent hair loss by blocking male hormones and stopping hair cell death.

Overexpressing AVP1 and AtNHX1 in plants improves salt tolerance and root hair development.

Vav2 and Vav3 proteins help control skin stem cell numbers and activity in both healthy and cancerous cells.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

GAPO syndrome causes growth issues, hair loss, missing teeth, and vision problems.

SVF injections improve hair growth and reduce hair loss in people with androgenic alopecia.

Avicennia marina extract can significantly promote hair growth in androgenic alopecia patients.

Avicennia marina extract and avicequinone C can potentially promote hair growth and treat hair loss by interfering with hair loss mechanisms and boosting growth factors.

Removing anthrax toxin receptor 1 in pigs prevents Senecavirus A infection and causes a rare disease similar to GAPO syndrome.

Using fat-derived cells to treat hair loss increased hair density and thickness without side effects.

Vogt-Koyanagi syndrome often leads to partial or complete blindness and responds poorly to treatment.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Androgenetic alopecia is linked to a higher risk of varicose veins, especially in men, but not to major vascular diseases.

Avacopan is generally safe, with some minor side effects like nausea and fatigue.

Vascular endothelial growth factor might be involved in common hair loss.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

VLDL could be an early warning sign for male pattern baldness.

VDAC2 promotes cell death in cashmere goat hair follicles through the P53 pathway.

Androgenetic alopecia is common, affects self-image, and has no complete cure yet.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

The model improves understanding of androgen interactions by focusing on signal intensity and system capacity.

Hair loss gene found on chromosome 3q26.

1′S-1′-Acetoxychavicol acetate may help treat hair loss by reducing oxidative stress.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Agouti and AGRP affect pigmentation and obesity, with implications for metabolic disorders.

A substance called Vascular Endothelial Growth Factor can protect certain hair follicle stem cells from damage caused by androgens, suggesting a new possible treatment for hair loss.